Management of Hypertension in the Very Elderly Patient
- 1 December 2004
- journal article
- case report
- Published by Wolters Kluwer Health in Hypertension
- Vol. 44 (6) , 800-804
Abstract
This Hypertension Grand Rounds discusses pharmacological treatment of hypertension in individuals who have survived 9 decades on earth. This rapidly growing group of relatively active and healthy elderly people is at high risk for hypertension, its treatment, and its adverse consequences, including stroke and heart failure. In this age group, the most common abnormality is elevated systolic blood pressure, which is much more predictive of stroke and heart disease death after 53 years of age. With the possible exception of the Antihypertensive and Lipid Lowering to prevent Heart Attack Trial (ALLHAT), recent clinical trials have emphasized the overriding importance of lowering blood pressure rather than the specific agent chosen to begin therapy. In 1999, a metaanalysis of 7 clinical trials that enrolled 1670 subjects >80 years of age indicated that active antihypertensive drug therapy significantly reduced stroke by 34% and heart failure by 39% but was associated with a nonsignificant 6% increase in mortality. The HYpertension in the Very Elderly Trial (HYVET) will enroll 2100 patients >80 years of age and will compare 2 groups randomized to indapamide±perindopril versus placebo±placebo for incident stroke during 5 years of follow-up. This study should answer lingering questions about whether active antihypertensive therapy is associated with a major and significant reduction in cardiovascular morbidity and mortality in this age group as it clearly does in younger hypertensives. Its choice of a diuretic as initial therapy is consistent with other trials, but chlorthalidone is the drug with the most compelling evidence in large US trials that included very elderly patients.Keywords
This publication has 30 references indexed in Scilit:
- Treatment of Octogenarians: Should We and How?The Journal of Clinical Hypertension, 2004
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003
- The influence of absolute cardiovascular risk, patient utilities and costs on the decision to treat hypertensionJournal Of Hypertension, 2003
- Trends in Prevalence, Awareness, Treatment, and Control of Hypertension in the United States, 1988-2000JAMA, 2003
- Cardiovascular prevention and blood pressure reductionJournal Of Hypertension, 2003
- Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studiesThe Lancet, 2002
- Selected major risk factors and global and regional burden of diseaseThe Lancet, 2002
- Residual Lifetime Risk for Developing Hypertension in Middle-aged Women and MenJAMA, 2002
- Effect of Treating Isolated Systolic Hypertension on the Risk of Developing Various Types and Subtypes of StrokeThe Systolic Hypertension in the Elderly Program (SHEP)JAMA, 2000
- Prevention of Stroke by Antihypertensive Drug Treatment in Older Persons With Isolated Systolic HypertensionJAMA, 1991